Caribou Biosciences Inc. (CRBU)
Caribou Biosciences Statistics
Share Statistics
Caribou Biosciences has 93M shares outstanding. The number of shares has increased by 2.97% in one year.
| 93M |
| 2.97% |
| 2.71% |
| 64.42% |
| 80.97M |
| 2,005 |
| 0.19% |
Short Selling Information
The latest short interest is 9.49M, so 10.21% of the outstanding shares have been sold short.
| 9.49M |
| 10.21% |
| 10.69% |
| 12.09 |
Valuation Ratios
The PE ratio is -0.96 and the forward PE ratio is -0.83. Caribou Biosciences's PEG ratio is -0.05.
| -0.96 |
| -0.83 |
| 14.37 |
| 0.1 |
| 0.57 |
| -1 |
| -0.05 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Caribou Biosciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7.16, with a Debt / Equity ratio of 0.1.
| 7.16 |
| 7.16 |
| 0.1 |
| -0.16 |
| -0.19 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $67,986.39 |
| $-1,014,319.73 |
| 147 |
| 0.03 |
| n/a |
Taxes
| -9K |
| 0.01% |
Stock Price Statistics
The stock price has increased by -35.9% in the last 52 weeks. The beta is 2.44, so Caribou Biosciences's price volatility has been higher than the market average.
| 2.44 |
| -35.9% |
| 0.9 |
| 1.54 |
| 64.39 |
| 1,053,492 |
Income Statement
In the last 12 months, Caribou Biosciences had revenue of 9.99M and earned -149.1M in profits. Earnings per share was -1.65.
| 9.99M |
| 6.07M |
| -166.62M |
| -149.1M |
| -166.62M |
| -166.62M |
| -1.65 |
Balance Sheet
The company has 16.29M in cash and 26.49M in debt, giving a net cash position of -10.19M.
| 16.29M |
| 26.49M |
| -10.19M |
| -448.39M |
| 273.66M |
| 188.83M |
Cash Flow
In the last 12 months, operating cash flow was -138.2M and capital expenditures -4.88M, giving a free cash flow of -143.08M.
| -138.2M |
| -4.88M |
| -143.08M |
| -1.58 |
Margins
Gross margin is 60.71%, with operating and profit margins of -1667.16% and -1491.95%.
| 60.71% |
| -1667.16% |
| -1492.04% |
| -1491.95% |
| -1667.16% |
| -1667.16% |
| -1431.66% |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CRBU is $8.5, which is 580% higher than the current price. The consensus rating is "Buy".
| $8.5 |
| 580% |
| Buy |
| 4 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -2.51 |
| 1 |